Literature DB >> 11252155

Menstrual migraine: diagnosis and treatment.

C L Lay1, A M Mascellino.   

Abstract

Of the nearly 20 million American women suffering with migraine, approximately 12 million experience a worsening of their migraines in association with their menstrual cycle. Prior to puberty the prevalence of migraine is slightly higher in boys; however, after puberty there is an emerging female predominance. Estrogen likely plays an important role in explaining this gender difference; however, hormones unlikely explain the entire epidemiologic variation. This article reviews the diagnosis and treatment options for menstrually associated migraine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11252155     DOI: 10.1007/s11916-001-0089-8

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  33 in total

1.  Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.

Authors:  J Schoenen; J Jacquy; M Lenaerts
Journal:  Neurology       Date:  1998-02       Impact factor: 9.910

2.  The role of estradiol withdrawal in the etiology of menstrual migraine.

Authors:  B W Somerville
Journal:  Neurology       Date:  1972-04       Impact factor: 9.910

3.  Rizatriptan in the treatment of menstrual migraine.

Authors:  S D Silberstein; H Massiou; C Le Jeunne; L Johnson-Pratt; K A McCarroll; C R Lines
Journal:  Obstet Gynecol       Date:  2000-08       Impact factor: 7.661

4.  Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo.

Authors:  N S Al-Waili
Journal:  Eur J Med Res       Date:  2000-04-19       Impact factor: 2.175

5.  Menstrual migraine: a double-blind trial of percutaneous estradiol.

Authors:  L Dennerstein; C Morse; G Burrows; J Oats; J Brown; M Smith
Journal:  Gynecol Endocrinol       Date:  1988-06       Impact factor: 2.260

6.  The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test.

Authors:  E M Lichten; J B Lichten; A Whitty; D Pieper
Journal:  Headache       Date:  1996-06       Impact factor: 5.887

7.  Continuous bromocriptine therapy in menstrual migraine.

Authors:  A G Herzog
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

8.  Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.

Authors:  O Lidegaard
Journal:  BMJ       Date:  1993-04-10

9.  Menstrual migraine: intermittent prophylaxis with a timed-release pharmacological formulation of dihydroergotamine.

Authors:  R D'Alessandro; G Gamberini; A Lozito; T Sacquegna
Journal:  Cephalalgia       Date:  1983-08       Impact factor: 6.292

10.  The neurobiology of vascular head pain.

Authors:  M A Moskowitz
Journal:  Ann Neurol       Date:  1984-08       Impact factor: 10.422

View more
  2 in total

Review 1.  The use of triptans in the management of menstrual migraine.

Authors:  Lisa K Mannix; Julia A Files
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Hormonal therapies for menstrual migraine.

Authors:  Anne H Calhoun; Susan Hutchinson
Journal:  Curr Pain Headache Rep       Date:  2009-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.